Editor in Chief:
Alain C. Borczuk, MD

ISSN: 0003-9985
eISSN: 1543-2165

Impact Factor
5.534

•DIAGNOSTIC STRATEGIES FOR ENDEMIC CORONAVIRUS DISEASE 2019 (COVID-19): RAPID ANTIGEN TESTS, REPEAT TESTING, AND PREVALENCE BOUNDARIES

•Elevated von Willebrand Factor Antigen is an Early Predictor of Mortality and Prolonged Length of Stay for Coronavirus Disease 2019 (COVID-19) Inpatients

•Risk-Assessment of Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients Using Laboratory Data and Immune Cell Morphological Assessment

•Early Antibody Temporal Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Vaccinated Subjects Determined by the Cobas 6000 Spike Assay

•Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment

•India's Second Wave of Coronavirus Disease 2019 (COVID-19) and the Lethal Outbreak of Black Fungus Infection

•Hofbauer cells and coronavirus disease 2019 (COVID-19) in pregnancy: Molecular pathology analysis of villous macrophages, endothelial cells, and placental findings from 22 placentas infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without fetal transmission

•A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases

•The Coronavirus Disease 2019 (COVID-19) Pandemic's Impact on Social Interaction in Pathology

•Defining Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placentitis: A Report of 7 Cases with Confirmatory In Situ Hybridization, Distinct Histomorphologic Features, and Evidence of Complement Deposition

•Future of Education or Present Reality: MD Anderson Cancer Center Hematopathology Virtual Educational Platform under Coronavirus Disease 2019 (COVID-19) Pandemic

•Evaluation of a Surrogate ELISA- Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation with IgG Commercial Serology Assays

•Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method

•Digital Pathology Initiatives and Experience of a Large Academic Institution During the Coronavirus Disease 2019 (COVID-19) Pandemic

•Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus, Intrauterine Transmission and Placental Pathology During the Coronavirus Disease 2019 (COVID-19) Pandemic: It's Complicated

•Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative IgG Assays: The Value of Numeric Reporting

•Continuing Undergraduate Pathology Medical Education in the Coronavirus Disease 2019 (COVID-19) Global Pandemic: The Johns Hopkins Virtual Surgical Pathology Clinical Elective

•Comparison of In Situ Hybridization, Immunohistochemistry and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2)-Testing in Tissue

•The Impact of Increasing Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance

•Histologic and Immunohistochemical Evaluation of 65 Placentas from Women with Polymerase Chain Reaction-proven Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

•Inter-laboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program

•A Postmortem Portrait of the Coronavirus Disease 2019 (COVID-19) Pandemic: A Large Multiinstitutional Autopsy Survey Study

•Chronic Histiocytic Intervillositis with Trophoblast Necrosis are Risk Factors Associated with Placental Infection from Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Liveborn and Stillborn Infants

•Design and Construction of a Biosafety Level-3 Autopsy Laboratory

•Operational Impacts of the coronavirus disease of 2019 (COVID-19) Pandemic and Early Recovery Trends: University of Washington Anatomic Pathology Experience

•Remote Fingerstick Blood Collection for SARS-CoV-2 Antibody Testing

•Experience with False Positive Test Results on the TaqPath Real-Time Reverse Transcription-PCR COVID-19 Testing Platform

•The Impact of the COVID-19 Pandemic on the 2019–2020 Job Search for Newly Trained Pathologists

•Barriers at the Scope: Use of Acrylic Shields at the Microscope During the Pandemic

•Histopathological features of Chilblain-like lesions developing in the setting of the COVID-19 pandemic

•Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic SARS CoV-2 Infection

•Testicular Changes Associated with SARS-CoV-2

•Transition from a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the COVID-19 Pandemic

•Risk Assessment of Autopsy-Acquired SARS-CoV-2 Coronavirus (COVID-19)

•In Reply

•Designing and Interpreting COVID-19 Diagnostics: Mathematics, Visual Logistics, and Low Prevalence

•Comparative Clinical Evaluation of the Roche Elecsys and Abbott SARS-CoV-2 Serology assays for COVID-19

•A novel “Google Classroom” based pathology education tool for trainees during COVID-19 pandemic: Impactful learning while social distancing

•The Spectrum of Histopathologic Findings in Lungs of Patients with Fatal COVID-19 Infection

•Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers

•Geospatial Spread of Antimicrobial Resistance, Bacterial and Fungal Threats to COVID-19 Survival, and Point-of-Care Solutions

•Confirming Vertical Fetal Infection with COVID-19: Neonatal and Pathology Criteria for Early Onset and Transplacental Transmission of SARS-CoV-2 from Infected Pregnant Mothers

•Mounting a Regional Response to the COVID-19 Pandemic: Another Reason to “Keep” Your Lab

•A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity

•Commercial SARS-CoV-2 Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG Cov Extended Panel and ID NOW COVID-19 Test

•Postmortem Swabs in the SARS-CoV-2 Pandemic: Report on 12 Complete Clinical Autopsy Cases

•Adrenal Vascular Changes in COVID-19 Autopsies

•Rapid Validation of Telepathology by an Academic Neuropathology Practice During the COVID-19 Pandemic

•Coagulation Dysfunction: A Hallmark in COVID-19

•COVID-19 Autopsies and Personal Protective Equipment

•Risk of COVID-19 Transmission During Autopsy

•Analysis of COVID-19 Transmission: Low Risk of Presymptomatic Spread?

•COVID-19 in a Hispanic Woman: Autopsy Report With Clinical Pathological Correlation

•Effects of SARS-CoV-2 Infection on Pregnant Women and Their Infants: A Retrospective Study in Wuhan, China

•Creation and Benefits of the “COVID Autopsy Listserve”

•SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice

•Leveraging Technology for Remote Learning in the Era of COVID-19 and Social Distancing: Tips and Resources for Pathology Educators and Trainees

•A Bayesian Analysis of Strategies to Rule Out COVID19 Using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

•Infections in Pregnancy With COVID-19 and Other Respiratory RNA Virus Diseases Are Rarely, If Ever, Transmitted to the Fetus: Experiences With Coronaviruses, HPIV, hMPV RSV, and Influenza

•COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation

•Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks: Ebola and Coronavirus

•Viral Transportation in COVID-19 Pandemic: Inactivated Virus Transportation Should Be Implemented for Safe Transportation and Handling at Diagnostics Laboratories

•An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes

Abstract and case study submissions to the College of American Pathologists (CAP) 2022 Abstract Program will be accepted beginning at 9 a.m. Monday, January 10 through 5 p.m. Central time Friday, March 11, 2022.Accepted submissions will appear on the Archives of Pathology Laboratory Medicine Web site as a Web-only supplement to the September 2022 issue. Awards will be presented to the winners of the Top 5 Junior Member Abstract Program.Click here for more information about submitting to the CAP22 Abstract Program.

Abstracts and case studies accepted for the CAP21 Virtual Abstract Program are available for viewing here.

Be sure to view the ePosters and MP4 files submitted by the authors of these accepted submissions here.

PubMed
ARCHIVES Twitter
ARCHIVES Facebook



CAP Annual Meeting Abstracts

Meetings

Sponsored Video

The Archives is the monthly, peer-reviewed medical journal of the College of American Pathologists. It offers global reach and the highest measured readership among pathology journals. Published since 1926, the Archives was voted in 2009 the only pathology journal among the top 100 most influential journals of the past 100 years by the Bio Medical and Life Sciences Division of the Special Libraries Association. Online access to the full-text and PDF files of Archives articles is free. The Archives is an official publication of the College of American Pathologists.

Not Yet Registered? While visitors to the Archives Web site are not required to register to have full access to published articles, the benefits of registration include:
The ability to save searches for subjects that interest you
The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers

Register Here